🔗 Permalink

Inventor profile of:

Isa ODIDI

City:

Toronto

Country:

Canada

Published Applications:

Last publication date:

2019-09-12

Top Assignees for applications by Isa ODIDI

The entities that hold a legal rights for patent applications filed by inventor ODIDI Isa:

INTELLIPHARMACEUTICS CORP 7 Toronto, Canada
Intellipharmaceutics Corp. 3 Ontario, Canada
INTELLIPHARMACEUTICS CORPORATION 2 Toronto, Ontario, Canada
Isa Odidi 2 Toronto, Canada
Intellipharmaceutics Corp. 1 Mississauga, Canada
Intellipharmaceutical Corp. 1 Mississauga, Canada
Biovail Corporation 1 Mississauga, Canada
INTELLIPHARMACEUTICS CORP. 1 Toronto, Ontario, Canada
INTELLIPHARMACEUTICS CORPORATION 1 Toronto, Canada

Recent patent applications by ODIDI Isa

Isa ODIDI from Toronto, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-09-12

US20190275153A1

Human necessities

Compositions and methods for reducing overdose

#2 | 2019-03-21

US20190083399A9

Human necessities

DRUG DELIVERY COMPOSITION

#3 | 2019-03-14

US20190076363A1

Human necessities

Controlled release delivery device comprising an organosol coat

#4 | 2018-11-22

US20180333362A1

Human necessities

Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems

#5 | 2018-09-04

US11315868

Human necessities

Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems

#6 | 2017-09-28

US20170273896A1

Human necessities

Controlled extended release pregabalin

#7 | 2017-09-14

US20170258912A1

Human necessities

Compositions and methods for reducing overdose

#8 | 2017-06-08

US20170157255A1

Human necessities

Compositions and methods for reducing overdose

#9 | 2017-04-27

US20170112770A1

Human necessities

Controlled release delivery device comprising an organosol coat

#10 | 2017-03-23

US20170079925A1

Human necessities

Compositions and methods for reducing overdose

#11 | 2017-03-23

US20170079924A1

Human necessities

Compositions and methods for reducing overdose

#12 | 2016-01-28

US20160022590A1

Human necessities

Compositions and methods for reducing overdose

#13 | 2015-10-22

US20150297734A1

Human necessities

Pharmaceutical composition having reduced abuse potential

#14 | 2015-09-10

US20150250733A1

Human necessities

ORAL DRUG DELIVERY FORMULATIONS

#15 | 2014-10-30

US20140322312A1

Human necessities

Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient

#16 | 2014-01-09

US20140010860A1

Human necessities

Abuse and alcohol resistant drug composition

#17 | 2013-04-18

US20130095176A1

Human necessities

CONTROLLED RELEASE DRUG DELIVERY COMPOSTION

#18 | 2009-12-10

US20090304787A1

Human necessities

DRUG DELIVERY COMPOSITION

#19 | 2009-09-17

US20090232887A1

Human necessities

Pharmaceutical composition having reduced abuse potential

#20 | 2009-09-03

US20090220613A1

Human necessities

Controlled release delivery device comprising an organosol coat

#21 | 2007-07-19

US20070166370A1

Human necessities

Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient

#22 | 2006-08-15

US10438776

Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum

#23 | 2006-02-23

US20060039976A1

Human necessities

Controlled release composition using transition coating, and method of preparing same

#24 | 2006-02-02

US20060024361A1

Human necessities

Disintegrant assisted controlled release technology

#25 | 2006-01-05

US20060003007A1

Human necessities

Controlled extended drug release technology

#26 | 2005-05-17

US9403437

Controlled release formulations using intelligent polymers

InventorID:

196906 ⎘